Table 1 Feasibility assessed through progression to trial criteria and their RAG boundaries: if Green, then progression is feasible; if Amber, then review of the intervention procedure would be necessary; if Red, then the component of the study would not be deemed deliverable during the cRCT
| Criterion | RAG |
|---|---|
| 1. Recruitment of a minimum of one patient per week per site (30 participants in 10 weeks across three sites). Assessed at 10 weeks after start of feasibility recruitment in each site |
Green: 8–10 patients Amber: 5–7 patients Red: 5 patients |
| 2. Patient reported receipt of My Medicines Toolkit (MMT)/Site checklist confirms patients received MMT |
Green: Evidence that patients received the MMT in all three trusts Amber: Evidence that patients received the MMT in two of three trusts Red: MMT only delivered in one trust |
| 3. Transfer of discharge advice and medicines letter to community pharmacies in all three sites—confirmed either by site checklist OR community pharmacy follow-up |
Green: Evidence that all three trusts able to communicate discharge advice letter to community pharmacy Amber: Evidence that two trusts able to transfer this information Red: Only evidence that one trust is able to transfer information |
| 4. Patients report/community pharmacy report the offer of a community pharmacy medicines review or medicines discussion OR community pharmacy reports completion of medicines reconciliation |
Green: Evidence that community pharmacies in all three areas able to offer review or perform medicines reconciliation Amber: Evidence that community pharmacies in two areas able to offer these services Red: Evidence that it has only been possible for community pharmacies in one area to offer these services |